Cambrex To Present At UBS Global Healthcare Conference
EAST RUTHERFORD, N.J., May 13, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will make a presentation on the Company at the UBS Global Healthcare Conference on May 20, 2013 at 1:00 p.m. EDT.
The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation
More by this Source
Cambrex Reports Fourth Quarter And Full Year 2013 Financial Results
Feb 11, 2014, 07:00 ET
Cambrex to Announce Fourth Quarter 2013 Financial Results on February 11, 2014
Feb 07, 2014, 14:46 ET
Cambrex Manufacturing Facility Completes Successful US FDA Inspection
Dec 16, 2013, 14:09 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.